A citation-based method for searching scientific literature

Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella, Arthur P Grollman, Tong-Chuan He, Yiping He, Ralph H Hruban, George I Jallo, Nils Mandahl, Alan K Meeker, Fredrik Mertens, George J Netto, B Ahmed Rasheed, Gregory J Riggins, Thomas A Rosenquist, Mark Schiffman, Ie-Ming Shih, Dan Theodorescu, Michael S Torbenson, Victor E Velculescu, Tian-Li Wang, Nicolas Wentzensen, Laura D Wood, Ming Zhang, Roger E McLendon, Darell D Bigner, Kenneth W Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Hai Yan. Proc Natl Acad Sci U S A 2013
Times Cited: 829



Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar. Science 2013
Times Cited: 1050




List of shared articles



Times cited

Glioblastoma and malignant melanoma: Serendipitous or anticipated association?
Kevin Yang, Thor D Stein, Bertrand R Huber, Emmett A Sartor, Jacob R Rachlin, Meera Mahalingam. Neuropathology 2021
0

Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.
Nighat Noureen, Shaofang Wu, Yingli Lv, Juechen Yang, W K Alfred Yung, Jonathan Gelfond, Xiaojing Wang, Dimpy Koul, Andrew Ludlow, Siyuan Zheng. Nat Commun 2021
1


Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction.
Shalu Sharma, Ananda Kishore Mukherjee, Shuvra Shekhar Roy, Sulochana Bagri, Silje Lier, Meenakshi Verma, Antara Sengupta, Manish Kumar, Gaute Nesse, Deo Prakash Pandey,[...]. Cell Rep 2021
0

Cancer regulatory variation.
Rebecca C Hennessey, Kevin M Brown. Curr Opin Genet Dev 2021
0

Telomeres: history, health, and hallmarks of aging.
Deepavali Chakravarti, Kyle A LaBella, Ronald A DePinho. Cell 2021
2

Human TERT promoter mutations as a prognostic biomarker in glioma.
Branka Powter, Sarah A Jeffreys, Heena Sareen, Adam Cooper, Daniel Brungs, Joseph Po, Tara Roberts, Eng-Siew Koh, Kieran F Scott, Mila Sajinovic,[...]. J Cancer Res Clin Oncol 2021
0

Telomerase reverse transcriptase promoter mutation- and O6-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?
Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, Marietta Wolter, Gabriele Schackert, Manfred Westphal, Luca Regli, Niklas Thon, Marcos Tatagiba, Wolfgang Wick,[...]. Eur J Cancer 2021
0

Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage.
Alexandra M Amen, Christof Fellmann, Katarzyna M Soczek, Shawn M Ren, Rachel J Lew, Gavin J Knott, Jesslyn E Park, Andrew M McKinney, Andrew Mancini, Jennifer A Doudna,[...]. Proc Natl Acad Sci U S A 2021
0

Biology of Melanoma.
Stephen M Ostrowski, David E Fisher. Hematol Oncol Clin North Am 2021
0

TERT Promoter Alterations in Glioblastoma: A Systematic Review.
Nathalie Olympios, Vianney Gilard, Florent Marguet, Florian Clatot, Frédéric Di Fiore, Maxime Fontanilles. Cancers (Basel) 2021
0

Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.
Rengyun Liu, Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu, Mingzhao Xing. Proc Natl Acad Sci U S A 2021
0

TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.
Edaise M da Silva, Pier Selenica, Mahsa Vahdatinia, Fresia Pareja, Arnaud Da Cruz Paula, Lorenzo Ferrando, Andrea M Gazzo, Higinio Dopeso, Dara S Ross, Ariya Bakhteri,[...]. NPJ Breast Cancer 2021
0


Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population.
Abdul K Siraj, Rong Bu, Kaleem Iqbal, Sandeep Kumar Parvathareddy, Nabil Siraj, Sarah Siraj, Mark Ranier F Diaz, Dionne Rae Rala, Allianah D Benito, Maria Angelita Sabido,[...]. Genomics 2020
1

Role of Heredity in Melanoma Susceptibility: A Primer for the Practicing Surgeon.
James F Abdo, Aayush Sharma, Rohit Sharma. Surg Clin North Am 2020
4

Telomere-related Markers for Cancer.
Xiaotian Yuan, Mingkai Dai, Dawei Xu. Curr Top Med Chem 2020
10

TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Paolo Boscolo-Rizzo, Silvia Giunco, Enrica Rampazzo, Martina Brutti, Giacomo Spinato, Anna Menegaldo, Marco Stellin, Monica Mantovani, Luigia Bandolin, Marco Rossi,[...]. J Cancer Res Clin Oncol 2020
4

TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients.
Rui Batista, Luís Lima, João Vinagre, Vasco Pinto, Joana Lyra, Valdemar Máximo, Lúcio Santos, Paula Soares. Int J Mol Sci 2020
11

Genomic footprints of activated telomere maintenance mechanisms in cancer.
Lina Sieverling, Chen Hong, Sandra D Koser, Philip Ginsbach, Kortine Kleinheinz, Barbara Hutter, Delia M Braun, Isidro Cortés-Ciriano, Ruibin Xi, Rolf Kabbe,[...]. Nat Commun 2020
19

Optimising gene editing for cancer therapy.
Katie Troike, Justin D Lathia. Nat Cell Biol 2020
1

TERT promoter mutations and telomeres during tumorigenesis.
Franziska K Lorbeer, Dirk Hockemeyer. Curr Opin Genet Dev 2020
12

Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy.
Daniele Lombardo, Carlo Saitta, Domenico Giosa, Francesca Casuscelli Di Tocco, Cristina Musolino, Giuseppe Caminiti, Valeria Chines, Maria Stella Franzè, Angela Alibrandi, Giuseppe Navarra,[...]. Oncol Lett 2020
7

CDK1 dependent phosphorylation of hTERT contributes to cancer progression.
Mami Yasukawa, Yoshinari Ando, Taro Yamashita, Yoko Matsuda, Shisako Shoji, Masaki Suimye Morioka, Hideya Kawaji, Kumiko Shiozawa, Mitsuhiro Machitani, Takaya Abe,[...]. Nat Commun 2020
5

TERT, a promoter of CNS malignancies.
Bhuvic Patel, Rukayat Taiwo, Albert H Kim, Gavin P Dunn. Neurooncol Adv 2020
6

Regulation of human telomerase in homeostasis and disease.
Caitlin M Roake, Steven E Artandi. Nat Rev Mol Cell Biol 2020
39

Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
Christine Pirker, Agnes Bilecz, Michael Grusch, Thomas Mohr, Barbara Heidenreich, Viktoria Laszlo, Paul Stockhammer, Daniela Lötsch-Gojo, Johannes Gojo, Lisa Gabler,[...]. Clin Cancer Res 2020
4

New tools to dissect the cancer genome.
Linah Shahoumi, Andrew Yeudall. Oral Dis 2020
0

Pervasive promoter hypermethylation of silenced TERT alleles in human cancers.
David Esopi, Mindy Kim Graham, Jacqueline A Brosnan-Cashman, Jennifer Meyers, Ajay Vaghasia, Anuj Gupta, Balasubramanian Kumar, Michael C Haffner, Christopher M Heaphy, Angelo M De Marzo,[...]. Cell Oncol (Dordr) 2020
2


Telomerase reverse transcriptase (TERT) promoter mutation correlated with intratumoral heterogeneity in hepatocellular carcinoma.
Wit Thun Kwa, Kathryn Effendi, Ken Yamazaki, Naoto Kubota, Mami Hatano, Akihisa Ueno, Yohei Masugi, Michiie Sakamoto. Pathol Int 2020
1

Telomeres and Telomerase in the Development of Liver Cancer.
Lena In der Stroth, Umesh Tharehalli, Cagatay Günes, André Lechel. Cancers (Basel) 2020
5

Telomeres and telomerase in oncogenesis.
Tomasz Trybek, Artur Kowalik, Stanisław Góźdź, Aldona Kowalska. Oncol Lett 2020
9